Outcome of Intensive Therapy for Children with Relapsed Acute Myeloid Leukemia: A Single Institution Korean Study

PURPOSE: Approximately 30%–40% of pediatric acute myeloid leukemia (AML) patients relapse. In this study, we analyzed the outcome and prognostic factors of relapsed AML patients who had previously received first-line therapy at our institution. MATERIALS AND METHODS: The study group consisted of 50...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Jae Wook, Yoo, Jae Won, Kim, Seongkoo, Jang, Pil-Sang, Chung, Nack-Gyun, Cho, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582462/
https://www.ncbi.nlm.nih.gov/pubmed/34922415
http://dx.doi.org/10.4143/crt.2021.1011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582462/
https://www.ncbi.nlm.nih.gov/pubmed/34922415
http://dx.doi.org/10.4143/crt.2021.1011

Ejemplares similares